The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Millions of cases of sexually transmitted infections (STIs) occur in the United States each year, resulting in substantial medical costs to the nation. Previous estimates of the total direct cost of STIs are quite dated. We present updated direct medical cost estimates of STIs in the United States. METHODS: We assembled recent (i.e., 2002-2011) cost estimates to determine the lifetime cost per case of 8 major STIs (chlamydia, gonorrhea, hepatitis B virus, human immunodeficiency virus (HIV), human papillomavirus, genital herpes simplex virus type 2, trichomoniasis and syphilis). The total direct cost for each STI was computed as the product of the number of new or newly diagnosed cases in 2008 and the estimated discounted lifetime cost per case. All costs were adjusted to 2010 US dollars. RESULTS: Results indicated that the total lifetime direct medical cost of the 19.7 million cases of STIs that occurred among persons of all ages in 2008 in the United States was $15.6 (range, $11.0-$20.6) billion. Total costs were as follows: chlamydia ($516.7 [$258.3-$775.0] million), gonorrhea ($162.1 [$81.1-$243.2] million), hepatitis B virus ($50.7 [$41.3-$55.6] million), HIV ($12.6 [$9.5-$15.7] billion), human papillomavirus ($1.7 [$0.8-$2.9] billion), herpes simplex virus type 2 ($540.7 [$270.3-$811.0] million), syphilis ($39.3 [$19.6-$58.9] million), and trichomoniasis ($24.0 [$12.0-$36.0] million). Costs associated with HIV infection accounted for more than 81% of the total cost. Among the nonviral STIs, chlamydia was the most costly infection. CONCLUSIONS: Sexually transmitted infections continue to impose a substantial cost burden on the payers of medical care in the United States. The burden of STIs would be even greater in the absence of STI prevention and control efforts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For females, the cost per STI case ranges from $247 for Human Papilloma Virus (HPV) to $804 for Herpes-Simples Virus (HSV2).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“The average cost per case of syphilis is $918 (either gender).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“For males, the cost per case ranges from $39 for Chlamydia to $985 for HSV2.”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
Citations
Cites
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893 · cited 1×
“However, this estimate is applicable when considering the best-case scenario of HIV care in the United States, implying that applying their estimate could overestimate the total direct cost of HIV, because not all patients with HIV receive care and not all those who receive care get the best care available.(25,26) Hut…”
BackgroundSexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Self-citationSexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,258
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Estimated HIV Incidence in the United States, 2006–2009
Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., Lin, L. S., An, Q., Mermin, J., Lansky, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017502 · Cited by 1,071 · cited 1×
“For instance, in the past few years, the reported annual incidence of chlamydia, syphilis, and genital warts has increased,(6) although the annual incidence of gonorrhea and HIV infection has been relatively stable.(6,7) In addition, given the rapid changes in health care technology and service delivery, the lifetime…”
BackgroundRisk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657 · cited 1×
“5% of treated asymptomatic cases in women, with no PID assumed to develop in treated women with symptomatic chlamydia.(15) We assumed epididymitis developed in 1.”
BackgroundThe Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444 · cited 8×
“Screening costs for asymptomatic persons were not included; in our previous estimate, these costs were included as part of the overall burden of chlamydia for persons infected with chlamydia.(1) We used previously published estimates of diagnosis and treatment costs for patients diagnosed in private physician/ health…”
BackgroundMethodResultInfluentialSelf-citationDevelopment and Duration of Human Papillomavirus Lesions, after Initial Infection
Winer, R. L., Kiviat, N. B., Hughes, J. P., Adam, D. E., Lee, S., Kuypers, J. M., & Koutsky, L. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427557 · Cited by 417
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States
Schackman, B. R., Gebo, K. A., Walensky, R. P., Losina, E., Muccio, T., Sax, P. E., Weinstein, M. C., Seage, G. R., Moore, R. D., & Freedberg, K. A. (2006) · Medical Care · doi:10.1097/01.mlr.0000228021.89490.2a · Cited by 410 · cited 5×
“We reviewed 2 recent studies that estimated the direct lifetime cost of HIV infection in the United States (Schackman et al.(23) and Hutchinson et al.”
BackgroundMethodInfluentialHs, M. (1995) · JAMA · doi:10.1001/jama.274.15.1201 · Cited by 323 · cited 1×
“For example, the potential costs of liver transplantation were included in the 3 source studies cited earlier, whereas liver transplantation costs were not reflected in our original estimate.(1,22)”
Background
Cited by
Items 201–300 of 463
Ulloa, C. E. G., Sepúlveda‐Crespo, D., García‐Broncano, P., Malý, M., Muñoz‐Fernández, M. Á., de la Mata, F. J., & Gómez, R. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.07.034 · Cited by 16
Schnitzler, L., Jackson, L. J., Paulus, A. T. G., Roberts, T. E., & Evers, S. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-07147-z · Cited by 17
Yao, H., Li, C., Tian, F., Liu, X., Yang, S., Xiao, Q., Jin, Y., Huang, S., Zhao, P., Ma, W., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1212890 · Cited by 15
Owusu‐Edusei, K., Nguyen, T. T. H., & Gift, T. L. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318285c58f · Cited by 15
Self-citationYuan, Z., He, C., Yan, S., Ke, Y., & Tang, W. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.03.031 · Cited by 15
Nicholls, J., Turner, K., North, P., Ferguson, R., May, M., Gough, K., Macleod, J., Muir, P., & Horner, P. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052942 · Cited by 15
Ki, M., Choi, H. Y., Han, M., & Oh, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.046 · Cited by 15
(2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.05.018 · Cited by 15
Lee, H., Lee, K., & Chong, Y. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1134315 · Cited by 15
“However, the lifetime costs per case estimated in the US were $79 for men and $354 for women in 2010 [13], and the total direct costs other than medical costs for adverse pregnancy outcomes were calculated as $197.”
BackgroundChesson, H. W., Kidd, S., Bernstein, K. T., Fanfair, R. N., & Gift, T. L. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000461 · Cited by 15
Self-citationA Public Health Response to Data Interoperability to Prevent Child Maltreatment
Nguyen, L. H. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302143 · Cited by 14
Owusu, C., Desjardins, M. R., Baker, K. M., & Delmelle, E. M. (2019) · Geospatial health · doi:10.4081/gh.2019.812 · Cited by 14
Factor Structure and Gender Stability in the Multidimensional Condom Attitudes Scale
Starosta, A. J., Berghoff, C. R., & Earleywine, M. (2014) · Assessment · doi:10.1177/1073191114547887 · Cited by 15
“Sexually transmitted infections (STIs) have approached epidemic status in the United States and appear to disproportionally affect younger members of the population.”
BackgroundInfluentialSexually transmitted diseases: An overview
Decker, C. F. (2016) · Disease-a-Month · doi:10.1016/j.disamonth.2016.03.008 · Cited by 14
Collar, A. L., Linville, A. C., Core, S. B., Wheeler, C. M., Geisler, W. M., Peabody, D. S., Chackerian, B., & Frietze, K. M. (2020) · mSphere · doi:10.1128/msphere.00654-20 · Cited by 14
Dendrimeric based microbicides against sexual transmitted infections associated to heparan sulfate
Diez, R. C., Sepúlveda‐Crespo, D., Maly, M., & Muñoz‐Fernández, M. Á. (2016) · RSC Advances · doi:10.1039/c6ra06969j · Cited by 15
Riley, B. H., & McDermott, R. C. (2018) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390318776369 · Cited by 17
Wigfall, L. T., Bynum, S. A., Brandt, H. M., Sebastian, N., & Ory, M. G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00422 · Cited by 14
Behavioral Decision Research Intervention Reduces Risky Sexual Behavior
Downs, J. S., de Bruin, W. B., Fischhoff, B., & Murray, P. J. (2015) · Current HIV Research · doi:10.2174/1570162x13666150511145328 · Cited by 17
“will spend over $15 billion on lifetime medical care to treat the sexually transmitted infections contracted in a single year[28], meaning that even fairly intensive prevention efforts have the potential to be cost-effective.”
BackgroundRodriguez‐Mateos, P., Ngamsom, B., Ameyo, D., Wakaba, P., Shiluli, C., Iles, A., Gitaka, J., & Pamme, N. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04734-3 · Cited by 13
“1 million [3], with over 600,000 cases being reported in the USA in 2019 (a 92% increase since the historic low in 2009) [4].”
Relationship between mental health diagnoses and sexually transmitted infections
Bretz, L. A., Keshwani, N. D., & Raphael, M. (2023) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.2023.87.2.115 · Cited by 16
Brannon, G. E., & Rauscher, E. A. (2018) · Health Communication · doi:10.1080/10410236.2018.1536951 · Cited by 13
Etiological Overlap Between Sex Under the Influence and Number of Lifetime Sexual Partners
Huibregtse, B. M., Hatoum, A. S., Corley, R. P., Rhea, S. A., Hewitt, J. K., & Stallings, M. C. (2020) · Behavior Genetics · doi:10.1007/s10519-020-10019-7 · Cited by 13
Toskin, I., Cooper, B., Troussier, T., Klugman, B., Kulier, R., Chandra‐Mouli, V., & Temmerman, M. (2015) · Reproductive Health Matters · doi:10.1016/j.rhm.2015.11.009 · Cited by 13
Sexually Transmitted Diseases in the Emergency Department
Pfennig, C. L. (2019) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2019.01.001 · Cited by 14
Williams, A. M., Gift, T. L., O’Donnell, L. N., RIETMEIJER, C. A. M., Malotte, C. K., Margolis, A. D., & Warner, L. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001109 · Cited by 13
Self-citationMhlanga, A. (2018) · Applied Mathematics and Nonlinear Sciences · doi:10.2478/amns.2018.2.00047 · Cited by 13
Steiner, R. J., Michael, S. L., Hall, J. E., Barrios, L. C., & Robin, L. E. (2013) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2013.09.008 · Cited by 13
Maria, D. S., Markham, C. M., Crandall, S. M., & Guilamo‐Ramos, V. (2016) · Public Health Nursing · doi:10.1111/phn.12262 · Cited by 14
Zou, Y., Liao, Y., Liu, F., Chen, L., Shen, H., Huang, S., Zheng, H., Yang, B., & Hao, Y. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000663 · Cited by 12
Johnson, B. L., Tesoriero, J. M., Feng, W., Qian, F., & Martin, E. G. (2017) · Health Services Research · doi:10.1111/1475-6773.12748 · Cited by 13
“…identified was the highest of all diseases ($20,255), this estimate is within the ceiling of $22,909 per new HIV diagnosis that is considered to be cost-saving, due to the high medical costs to treat HIV infection (Farnham, Sansom, and Hutchinson 2012; Owusu-Edusei et al. 2013; Huang et al. 2014).”
Munson, E. L., Napierala, M., & Schell, R. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.814429 · Cited by 13
HIV Screening Rates among Medicaid Enrollees Diagnosed with Other Sexually Transmitted Infections
Adekeye, O. A., Abara, W. E., Xu, J., Lee, J. M., Rust, G. S., & Satcher, D. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161560 · Cited by 12
Batteiger, B. E., & Tan, M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00182-x · Cited by 16
Owusu‐Edusei, K., & Chang, B. A. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001078 · Cited by 12
Self-citationExpedited Partner Therapy: Combating Record High Sexually Transmitted Infection Rates
Jamison, C. D., Chang, T., & Mmeje, O. O. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304570 · Cited by 12
Misinde, C., Nansubuga, E., & Nankinga, O. (2018) · BMC Public Health · doi:10.1186/s12889-018-6094-1 · Cited by 16
Villa, L., Boga, J. A., Otero, L., Vázquez, F., Milagro, A., Salmerón, P., Vall-Mayans, M., Macia, M. D., Bernal, S., & Piñeiro, L. (2023) · Antibiotics · doi:10.3390/antibiotics12060975 · Cited by 12
Behavioral Prevention Regarding Sexually Transmitted Infections and its Predictors in Women
Khalili, A. F., Shahnazi, M., Salehi‐Pourmehr, H., Faridvand, F., & Asgarloo, Z. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.18346 · Cited by 11
Jenner, E., Jenner, L. W., Walsh, S. K., Demby, H., Gregory, A., & Davis, E. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303291 · Cited by 11
Chesson, H. W., Ludovic, J. A., Berruti, A. A., & Gift, T. L. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000747 · Cited by 11
“Following the source study on which the lifetime cost values were obtained per STI, we varied the base case value by ±50%.(20) For HIV, the range of values we applied represents the lower and upper bound values in the source study when the CD4 count at time of diagnosis was varied.”
Self-citationA Youth Participatory Project to Address STIs and HIV among Homeless Youth
Dang, M. T., Amos, A., Dangerfield, M., Ford, B., Kern, K., & Moon, M. W. (2018) · Comprehensive Child and Adolescent Nursing · doi:10.1080/24694193.2018.1483980 · Cited by 11
“In addition, STDs are estimated to cost the U.S. health-care system $16 billion annually (Owusu-Edusei et al., 2013).”
BackgroundA Systematic Literature Review of Reviews on the Effectiveness of Chlamydia Testing
Wong, W. C. W., Lau, S. T. H., Choi, E. P. H., Tucker, J. D., Fairley, C. K., & Saunders, J. (2019) · Epidemiologic Reviews · doi:10.1093/epirev/mxz007 · Cited by 12
Harry, M. L., Asche, S. E., Freitag, L. A., Sperl‐Hillen, J. M., Saman, D. M., Ekstrom, H. L., Chrenka, E. A. B., Truitt, A. R., Allen, C. I., O’Connor, P. J., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2040933 · Cited by 12
Situational Influences on Condom Purchasing
Young, T. M., Marks, M. J., Zaikman, Y., & Zeiber, J. A. (2017) · Sexuality & Culture · doi:10.1007/s12119-017-9431-0 · Cited by 11
“In the United States alone, over three billion dollars a year in medical care is spent detecting and treating STIs and related complications (Owusu-Edusei et al. 2013).”
BackgroundLee, A. J., Montgomery, M. C., Patel, R. R., Raifman, J., Dean, L. T., & Chan, P. A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000727 · Cited by 11
Pugsley, R. A., & Peterman, T. A. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000922 · Cited by 11
Jones, A. T., Craig-Kuhn, M. C., Schmidt, N., Gomes, G. R., Scott, G., Watson, S., Hines, P., Davis, J., Lederer, A. M., Martin, D. H., et al. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001325 · Cited by 11
Young adults with depression are at increased risk of sexually transmitted disease
Jenkins, W. D., & Botchway, A. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.03.020 · Cited by 12
Patton, D. L., SWEENEY, Y. T. C., Baldessari, A. E., Cles, L. D., Kari, L., Sturdevant, G. L., Yang, C., & Caldwell, H. D. (2018) · Infection and Immunity · doi:10.1128/iai.00121-18 · Cited by 11
“3 million new cases of genital chlamydial infections occur annually in women ages 15 to 39 (2), at an estimated annual cost of $520 million dollars (3).”
BackgroundHabel, M. A., Haderxhanaj, L. T., Hogben, M., Eastman-Mueller, H. P., Chesson, H. W., & Roberts, C. M. (2015) · PubMed · Cited by 11
Self-citationMcSheffrey, G. G., & Gray‐Owen, S. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00082-2 · Cited by 11
Young Adults Make Rational Sexual Decisions
Hatz, L. E., Park, S., McCarty, K. N., McCarthy, D. M., & Davis‐Stober, C. P. (2020) · Psychological Science · doi:10.1177/0956797620925036 · Cited by 12
A need for trauma informed care in sexually transmitted disease clinics
Brewer, A., Colbert, A. M., Sekula, K. L., & Bekemeier, B. (2020) · Public Health Nursing · doi:10.1111/phn.12784 · Cited by 10
Lee, S. W. H., Gottlieb, S. L., & Chaiyakunapruk, N. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049618 · Cited by 13
Li, Y., Rönn, M. M., Tuite, A. R., Chesson, H. W., Gift, T. L., Trikalinos, T. A., Testa, C., Bellerose, M., Hsu, K., Berruti, A. A., et al. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100364 · Cited by 12
Self-citationOpportunities and barriers to STI testing in community health centres in China: a nationwide survey
Ong, J. J., Peng, M., Zhu, S., Lo, Y.-R. J., Fairley, C. K., Kidd, M. R., Roland, M. O., Jiang, S., & Wong, W. C. W. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053196 · Cited by 10
Human Acute and Chronic Viruses: Host-Pathogen Interactions and Therapeutics
Hoffman, M., Chigbu, D. I., Crumley, B. L., Sharma, R. K., Pustylnikov, S., Crilley, T. A., Ginwala, R., Loonawat, R., Joseph, J., Sales, D., et al. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_1 · Cited by 12
Chan, J. K., Mann, A. K., Lee, D., Rohatgi, A. P., Chan, C., Abel, M. K., Argueta, C., & Kapp, D. S. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001410 · Cited by 10
Hao, Z., Guo, Y., Bowling, J., & Ledenyi, M. (2021) · International Journal of Sexual Health · doi:10.1080/19317611.2021.1989535 · Cited by 11
Differences in Treatment of Chlamydia trachomatis by Ambulatory Care Setting
Pearson, W. S., Gift, T. L., Leichliter, J. S., & Jenkins, W. D. (2015) · Journal of Community Health · doi:10.1007/s10900-015-0037-x · Cited by 10
Self-citationA Learning Collaborative Approach to Improve Primary Care STI Screening
McKee, M. D., Alderman, E. M., York, D. V., Blank, A. E., Briggs, R. D., Hoidal, K. E. S., Kus, C. A., Lechuga, C., Mann, M. Y., Meißner, P., et al. (2017) · Clinical Pediatrics · doi:10.1177/0009922817733702 · Cited by 10
Owusu‐Edusei, K., Sayegh, B. J., Harvey, A., & Nelson, R. J. (2014) · Sexual Health · doi:10.1071/sh14057 · Cited by 9
Self-citationThe Affordability of Providing Sexually Transmitted Disease Services at a Safety-net Clinic
Dean, L. T., Montgomery, M. C., Raifman, J., Nunn, A. S., Bertrand, T. E., Almonte, A. A., & Chan, P. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.12.016 · Cited by 9
Lee, S.-C., Hu, C.-K., Hung, J.-H., Yang, A. C., Tsai, S., Huang, M.-W., Hu, L., & Shen, C. (2018) · Oncotarget · doi:10.18632/oncotarget.24780 · Cited by 10
Lifetime Medical Costs of Genital Herpes in the United States: Estimates From Insurance Claims
Eppink, S. T., Kumar, S., Miele, K., & Chesson, H. W. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001371 · Cited by 9
Self-citationA measure of centrality in cyclic diffusion processes: Walk-betweenness
Youm, Y., Lee, B., & Kim, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245476 · Cited by 9
The economic impact of Project MARS (Motivating Adolescents to Reduce Sexual Risk).
Dealy, B. C., Horn, B. P., Callahan, T. J., & Bryan, A. D. (2013) · Health Psychology · doi:10.1037/a0033607 · Cited by 11
Improving STD Screening Rates on a University Campus
Myers, A., McCaskill, S. P., & VanRavenstein, K. (2017) · Journal of Community Health · doi:10.1007/s10900-017-0377-9 · Cited by 9
“These cost estimates for gonorrhea and chlamydia do not include overall burden: missed productivity, pain and suffering, or the cost of screening [3].”
BackgroundLizárraga, D., Carver, S., & Timms, P. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1698954 · Cited by 8
Abad, S. E., Neira, E., Atancuri, L. C. V., Escandón, S., & Neira, V. A. (2022) · Infectious Disease Reports · doi:10.3390/idr14050070 · Cited by 8
Chan, M. S., Lohmann, S., Morales, A., Zhai, C., Ungar, L., Holtgräve, D. R., & Albarracín, D. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2046-0 · Cited by 8
Camacho-Gutíerrez, J. A., Saldaña, F., Barradas, I., & Jerez, S. (2019) · Bulletin of Mathematical Biology · doi:10.1007/s11538-019-00642-9 · Cited by 8
Li, T., Liu, Z., Zhang, D., Liao, Q., Fan, S., Hao, M., Hong, Y., Huang, X., Wang, H., Xiong, Z., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1182108 · Cited by 8
Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users
Stephens, D. B., Young, A. M., Mullins, U. L., & Havens, J. R. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24358 · Cited by 9
“7 million in 2008, a total exceeded only by HIV and human papillomavirus [Owusu-Edusei et al., 2013].”
BackgroundInfluentialRigholt, C. H., Pabla, G. S., & Mahmud, S. M. (2018) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0367-1 · Cited by 8
John, S. A. (2018) · Sexuality Research and Social Policy · doi:10.1007/s13178-017-0316-7 · Cited by 8
Saberi, P., Neilands, T. B., Lally, M., Hosek, S., & Hightow‐Weidman, L. (2019) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325958219867324 · Cited by 9
Grieshaber, N. A., Runac, J., Turner, S. M., Dean, M., Appa, C., Omsland, A., & Grieshaber, S. S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.692224 · Cited by 8
Variations in Measurement of Sexual Activity Based on EHR Definitions
Berlan, E. D., Ireland, A. M., Morton, S., Byron, S. C., Canan, B. D., & Kelleher, K. J. (2014) · PEDIATRICS · doi:10.1542/peds.2013-3232 · Cited by 8
Marcell, A. V., Gibbs, S., Howard, S., Pilgrim, N. A., Jennings, J. M., Arrington‐Sanders, R., Page, K. R., Loosier, P. S., & Dittus, P. (2017) · American Journal of Men s Health · doi:10.1177/1557988317696640 · Cited by 9
“…15, 2016; revised January 11, 2017; accepted January 13, 2017 school, unemployment, lower earning, poor infant outcomes, infertility, ectopic pregnancy) and societal costs (~$25 billion) nationally (Owusu-Edusei et al., 2013; The National Campaign to Prevent Teen and Unplanned Pregnancy, 2013).”
BackgroundRural counties chlamydia and gonorrhea rates in Pennsylvania among adolescents and young adults
Pinto, C. N., Dorn, L. D., Chinchilli, V. M., Du, P., & Chi, G. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.08.018 · Cited by 9
“17 The cubic polynomial spline regression model was structured to be continuous and differentiable at the nodes, and the model included (1) terms to account for seasonal variation and (2) an autoregressive process to account for correlation.”
MethodSexually transmitted infections
Kamb, M. L., & Garcia, P. J. (2015) · doi:10.1093/med/9780199661756.003.0212 · Cited by 9
Pearson, W. S., Kumar, S., Habel, M. A., Walsh, S., Meit, M. B., Barrow, R. Y., Weiss, G., & Gift, T. L. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106411 · Cited by 8
Self-citationSeiler, N., Horton, K. B., Pearson, W. S., Cramer, R. C., Adil, M., Bishop, D., & Heyison, C. (2021) · Public Health Reports · doi:10.1177/0033354920985476 · Cited by 8
Castaño, M. J., Guillem, J., Ripoll, J. J., Navarro, D., & Albert, E. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116700 · Cited by 7
Simultaneous Alcohol and Cannabis Use and High-Risk Sexual Behaviors
Kolp, H. M., Horvath, S. A., Munoz, E. A., Metrik, J., & Shorey, R. C. (2023) · Cannabis · doi:10.26828/cannabis/2023/000134 · Cited by 8
“The treatment of STIs is costly, totaling approximately $15.6 billion in the United States per year (Owusu-Edusei et al., 2013).”
BackgroundInfluentialOwusu‐Edusei, K., Gift, T. L., Leichliter, J. S., & Romaguera, R. A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000692 · Cited by 7
Self-citationKawamura, Y., Komoto, S., Fukuda, S., Kugita, M., Táng, S., Patel, A., Pieknik, J. R., Nagao, S., Taniguchi, K., Krause, P. R., et al. (2023) · Microbiology and Immunology · doi:10.1111/1348-0421.13107 · Cited by 7
“7 Although suppressive antiviral therapy reduces the frequency of genital herpes recurrences by 70% – 80% among patients who have frequent recurrences, 8 there is no curative antiviral treatment for genital herpes because HSV can latently infect sensory ganglia and anti ‐ HSV drugs are only e ff…”
BackgroundTemporal analysis of social determinants associated with COVID-19 mortality
Debopadhaya, S., Erickson, J. S., & Bennett, K. P. (2021) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3459930.3469535 · Cited by 10
HSV-2 and Substance Abuse amongst Adolescents: Insights through Mathematical Modelling
Mhlanga, A., Bhunu, C. P., & Mushayabasa, S. (2014) · Journal of Applied Mathematics · doi:10.1155/2014/104819 · Cited by 7
“In the United States of America (USA), annual health costs for STIs has reachedUS $17Billion [3], withHSV2 chewing up $541million,making it the thirdmost costly STI after HIV-1 and human papillomavirus (HPV) [4].”
BackgroundMajor Depressive Disorder and Condom Use in Young Adult Females
Cooke, T. (2016) · Psychiatry Depression & Anxiety · doi:10.24966/pda-0150/100006 · Cited by 7
Mehtani, N. J., Schumacher, C. M., Johnsen, L. E., Greenbaum, A. H., Chaulk, C. P., Ghanem, K. G., Jennings, J. M., & Page, K. R. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.03.019 · Cited by 7
Gonorrhea and Chlamydia Cases Are Rising in the United States: Expedited Partner Therapy Might Help
Nelson, T., Nandwani, J. K., & Johnson, D. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001479 · Cited by 7
Examining Fluoroquinolone Claims Among Gonorrhea-Associated Prescription Drug Claims, 2000–2010
Owusu‐Edusei, K., Carroll, D., & Gift, T. L. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.04.031 · Cited by 6
Self-citationKockaya, G., Kose, A., Yenilmez, F. B., Özdemir, O., & Kucuksayrac, E. (2015) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-015-0046-8 · Cited by 6
Kumar, S., Chesson, H. W., & Gift, T. L. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001266 · Cited by 6
Self-citationSacca, L., Doumat, G., Rihan, A., Maroun, J., & Ejezie, C. L. (2023) · American Journal of Health Education · doi:10.1080/19325037.2023.2187486 · Cited by 6
Chen, A. C., & Amresh, A. (2015) · International Conference on Digital Health · doi:10.1145/2750511.2750522 · Cited by 7
“Annual healthcare costs related to HPV infections are about $1.7 billion [2], similar to the direct medical costs associated with HIV infection among individuals aged 15-24 years old [3].”
BackgroundInfluentialWalsh, S. K., Jenner, E., Leger, R., & Broussard, M. (2015) · American Journal of Health Behavior · doi:10.5993/ajhb.39.5.3 · Cited by 6
Metadata
- Authors
- Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C. B., & Kent, C. K.
- Corresponding author
- Chesson, Harrell W.
- Gift, Thomas L.
- Tao, Guoyu
- Kent, Charlotte K.
- Venue
- Sexually Transmitted Diseases
- Published
- 2013-03
- Volume
- 40
- Issue
- 3
- Pages
- 197-201
- ISSN
- 0148-5717 (ISSN-L)
- OpenAlex
- W2064915358
- Cited by
- 452
- References
- 32
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 9 · 2023: 20 · 2022: 21 · 2021: 37 · 2020: 39 · 2019: 39 · 2018: 45 · 2017: 75 · 2016: 41 · 2015: 46 · 2014: 53 · 2013: 17
- FWCI
- 47.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Sexually Transmitted Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- sexually transmitted infections, direct medical costs, HIV, chlamydia, gonorrhea, hepatitis B virus, human papillomavirus, herpes simplex virus type 2, syphilis, trichomoniasis, cost burden
- MeSH terms
- Chlamydia Infections, Condylomata Acuminata, Female, Gonorrhea, Hepatitis B, Herpes Genitalis, Humans, Male, Sexually Transmitted Diseases, Syphilis, Trichomonas Infections, United States, HIV Infections, Health Care Costs, Cost of Illness, Models, Economic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.